Taskforce: Resources for Pharmacy Professionals

[Updated 05.19.20]

This page contains the most current resources and information created or compiled by the CPhA COVID-19 taskforce. This is an ongoing and developing situation with new information available on a daily basis. Please use this page to access the most current updates. For general resources and updates, visit our COVID-19 webpage at https://cpha.com/covid19/.

Board of Trustees Position Statements on COVID-19: The California Pharmacists Association Board of Trustees (CPhA BOT) has released position statements on the topics of “Protecting pharmacy personnel during public health crisis”, “Pharmaceutical safety and access during emergencies”, and “Scope of practice”. Published March 23, 2020. Last updated April 7, 2020.

Recommendations for Infection Control Standards and Precautions for Pharmacy Personnel: A collection of recommendations for infection control standards and precautions for pharmacy employers, personnel, and patients in the pharmacy setting amidst the COVID-19 pandemic. Published March 27, 2020. Last updated April 17, 2020.

Return to Work Criteria for Healthcare Personnel: A flowchart to determine when it is appropriate for employees to return to work after having confirmed or suspected infection with COVID-19. Published March 31, 2020. 

Exposure to COVID-19 in the Workplace: A collection of recommendations for how to handle confirmed or potential exposure in the pharmacy setting, including information for employers, facilities and personnel and a flow chart for risk assessment of personnel.  Published April 13, 2020.

COVID-19 Testing Overview: An overview of COVID-19 tests and answers to frequently asked questions from pharmacy professionals regarding testing. Published April 23, 2020.

Summary Table of COVID tests: A summary of current FDA approved COVID-19 tests which will be updated on a weekly basis, as needed. Published April 29, 2020. Last updated May 19, 2020.

COVID-19 Testing Pathways: A resource outlining the two distinct testing approaches and considerations for pharmacists. Published April 17, 2020.

Point of Care Testing (POCT):  A decision tree for pharmacists ordering or administering point of care tests (POTC) with specific considerations. Published April 22, 2020.

COVID-19 Laboratory Test:  A decision tree for pharmacists ordering laboratory tests for COVID-19 with specific considerations. Published April 28, 2020.

HRSA COVID-19 Uninsured Program: CPhA letter with information about Medicare Reimbursement for COVID-19 Testing & Treatment. Published April 29, 2020.

Information in the works:

  • Template Screening Forms for COVID-19 Testing: Coming soon. 
  • Relevant Billing Codes for COVID-19 Testing: Coming soon.
  • Informational Videos on COVID-19, hand hygiene, use of gloves, and use of masks: Coming soon.


COVID-19 Testing Considerations:

Providers should report COVID-19 test results to their local public health departments.

COVID-19 Claims Reimbursement: 

  • Medicare Payment: CMS announces a pathway for the pharmacy billing of COVID-19 tests through Medicare.
  • HRSA COVID-19 Uninsured Program:  COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing and Treatment of the Uninsured
  • Guidance Documents
    • NCPDP Issues COVID-19 Guidance for Pharmacy-led Testing: NCPDP Emergency Preparedness Information document provides guidance to assist pharmacists in their expanded role of administering tests, including serology tests, and other services in the COVID-19 pandemic and global public health crisis.
    • CMS Rule Update for Pharmacists: CMS released new regulations addressing pharmacists’ testing and patient care services during the COVID-19 pandemic.

COVID-19 Treatment Guidelines:

Assessment of Evidence for COVID-19-Related Treatments: ASHP provides an evidence table, that is regularly updated, to help practitioners better understand current approaches related to treatment and care.

NIH LitCovid: LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus, providing central access to relevant articles in PubMed.

Nasopharyngeal Specimen Collection Training: This training module will provide you with the information you need to safely collect COVID-19 specimens for testing. It will cover the use of Personal Protective Equipment (PPE) and the proper technique for collecting COVID-19 specimens for testing.

CPR/BLS/ACLS Resources for Healthcare Providers</span: American Heart Association (AHA) updates CPR guidelines to address patients with COVID-19.


California Department of Public Health (CDPH): Guidance documents from the California Department of Public Health.


FDA Emergency Use Authorizations (EUA):  This page lists current and terminated Emergency Use Authorizations that make available diagnostic and therapeutic medical devices to diagnose and respond to public health emergencies. This includes EUAs for Personal Protective Equipment, In Vitro Diagnostic, and Ventilators and Other Medical Device for COVID-19.

FDA Emergency Use Authorizations (EUA) – Therapeutics: This page lists current Emergency Use Authorizations for COVID-19 therapeutics.

Guidance for Healthcare Facilities during the COVID-19 Pandemic: CDC Guidance on infection prevention and control recommendations for healthcare settings

Guidance for Pharmacies during the COVID-19 Pandemic: CDC guidance for pharmacy staff to minimize risk of exposure to the virus and reduce the risk for customers during the COVID-19 pandemic.

Guidance for Outpatient and Ambulatory Settings during the COVID-19 Pandemic: CDC guidance for minimize risk of exposure to COVID-19 in ambulatory care settings, including community health centers, retail clinics co-located in pharmacies, grocery stores, or mass merchants, hospital-based outpatient clinics, and non-hospital-based clinics.

Additional CDC Recommendations for Healthcare Personnel:

Guidance for Healthcare Professionals

Guidance for Businesses & Employers

Clinical Questions – FAQ

Cleaning and Disinfecting Your Facility

Criteria for Return to Work

Decontamination and Reuse of Filtering Facepiece Respirators

Diagnostic Testing for SARS-COV-2 – FAQ

Evaluating and Testing for COVID-19

Risk Assessment of Healthcare Personnel with Potential Exposure 

Personal Protective Equipment (PPE) Burn Rate Calculator

PPE – Sequence for Donning & Removing Gown, Mask, Googles, Gloves

Strategies to Mitigate Staffing Shortages

Strategies to Optimize the Supply of PPE and Equipment

Therapeutic Options

Vaccines – Delivery of Adult Immunizations

Vaccines – Maintaining Childhood Immunizations


OSHA Guidance on Control and Prevention of COVID-19:  OSHA has developed guidance documents for employers to protect workers and prevent exposure to COVID-19.

Apply for CLIA Certificate: Pharmacies who want to become a laboratory for the purpose of performing point-of-care tests should apply for a CLIA Certificate of Waiver. In California, both state forms (California Department of Public Health) and federal forms (CMS) must be completed.

Drug Shortage Resource: Log into the AHSF Drug Information Database using complementary credentials provided by ASHP (Username: ahfs@ashp.org; Password: covid-19). Click on the Shortages tab to view more information. Available for a limited time.

Community Pharmacy Best Practices for COVID-19 from CPESN® USA Pharmacies: Pharmacy focused strategies, protocols, and other practice tools that are being used by community-based pharmacies in a clinically integrated, nationwide Accountable Pharmacy Organizations.

Practical Information for Pharmacists to Know: APhA provides practice-based resources for pharmacists, including clinical-care of patients and managing your pharmacy.

Information from the Joint Commission: Resources and guidance from the Joint Commission during COVID-19.  

Information from the Drug Enforcement Administrations (DEA): Resources and guidance from the DEA for prescribers and pharmacists during COVID-19.

Pharmacy Law Waivers from the California Board of Pharmacy: Current pharmacy law waivers issued by the California Board of Pharmacy during the declaration of emergency due to COVID-19. Please contact us for questions about waivers and click here for information on how to request a waiver.


The CPhA COVID-19 taskforce is composed of members with expertise in infectious disease, community and health-systems pharmacy practice settings, government relations, and public health as it pertains to pandemics. The Taskforce meets on a semiweekly basis to discuss, evaluate, and approve recommendations and resources to keep CPhA members informed of the latest developments related to COVID-19. 

The taskforce members include: Richard Dang, PharmD, APh, BCACP (Chair) (Assistant Professor of Clinical Pharmacy, USC School of Pharmacy);  Naomi Florea, PharmD (Chief Pharmacy Officer, Choice Care Concierge Medicine); Jeff Goad, PharmD, MPH, FAPhA, FCPhA, FCSHP (Professor, Chair, Department of Pharmacy Practice, Chapman University School of Pharmacy); David Ha, PharmD, BCIDP (ASP/Infectious Disease Pharmacist, Stanford Medicine); Virginia (Giny) Herold (Former Executive Officer of the California Board of Pharmacy); and Linh Lee, PharmD (Director of Health and Wellness/Pharmacy, Ralphs Grocery Company).

For any questions or inquiries, please email Rajan Vaidya, PharmD (Director, Pharmacy Practice & Policy) at rvaidya@cpha.com or click here.